Total Payments
$2,271
2024 Payments
$150.74
Companies
26
Transactions
160
Medicare Patients
2,504
Medicare Billing
$246,738
Payment Breakdown by Category
Food & Beverage$2,262 (99.6%)
Education$9.37 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,262 | 158 | 99.6% |
| Education | $9.37 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $456.46 | 40 | $0 (2024) |
| PFIZER INC. | $211.10 | 11 | $0 (2024) |
| ABBVIE INC. | $188.85 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $168.15 | 18 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $136.01 | 8 | $0 (2020) |
| Merck Sharp & Dohme LLC | $110.86 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $107.70 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $100.05 | 8 | $0 (2022) |
| Astellas Pharma US Inc | $97.80 | 6 | $0 (2020) |
| Lilly USA, LLC | $81.16 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.74 | 8 | ABBVIE INC. ($40.03) |
| 2023 | $102.28 | 5 | ABBVIE INC. ($34.47) |
| 2022 | $156.74 | 9 | Novo Nordisk Inc ($35.84) |
| 2021 | $200.24 | 12 | AbbVie Inc. ($89.30) |
| 2020 | $379.78 | 29 | Novo Nordisk Inc ($128.25) |
| 2019 | $368.34 | 26 | Novo Nordisk Inc ($80.41) |
| 2018 | $407.07 | 32 | Novo Nordisk Inc ($105.87) |
| 2017 | $506.20 | 39 | Janssen Pharmaceuticals, Inc ($118.11) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/25/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: WOMENS HEALTH | ||||||
| 04/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Oncology | ||||||
| 03/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: VACCINE | ||||||
| 03/07/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
| 02/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Cardiovascular | ||||||
| 12/12/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/28/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Obesity | ||||||
| 08/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Cardiovascular | ||||||
| 07/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Diabetes | ||||||
| 04/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2022 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: VACCINES | ||||||
| 01/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: PRIMARY CARE | ||||||
| 12/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 478 | 658 | $111,448 | $53,359 |
| 2022 | 10 | 531 | 727 | $123,780 | $59,319 |
| 2021 | 10 | 580 | 782 | $101,765 | $58,191 |
| 2020 | 22 | 915 | 1,228 | $153,265 | $75,870 |
Total Patients
2,504
Total Services
3,395
Medicare Billing
$246,738
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 261 | $49,851 | $20,827 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $29,592 | $14,456 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 85 | $11,205 | $4,487 | 40.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $4,768 | $4,177 | 87.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 19 | $7,435 | $3,966 | 53.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 23 | 23 | $2,062 | $1,716 | 83.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 18 | $2,017 | $950.25 | 47.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $805.00 | $788.68 | 98.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 13 | $1,521 | $632.90 | 41.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 34 | 34 | $1,191 | $585.82 | 49.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $528.00 | $517.38 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 25 | $473.00 | $254.42 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 296 | $55,352 | $24,605 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 145 | 145 | $36,105 | $18,363 | 50.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 26 | 30 | $11,550 | $6,242 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 73 | $9,417 | $3,722 | 39.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 35 | $4,515 | $2,068 | 45.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 21 | 21 | $1,554 | $1,468 | 94.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 23 | 23 | $2,691 | $1,129 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 30 | $870.00 | $837.18 | 96.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 26 | 26 | $910.00 | $460.24 | 50.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 48 | $816.00 | $425.36 | 52.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 261 | $38,106 | $21,014 | 55.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 145 | 145 | $33,481 | $18,590 | 55.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 23 | 28 | $10,380 | $6,332 | 61.0% |
About Dr. Anthony Marl, DO
Dr. Anthony Marl, DO is a Internal Medicine healthcare provider based in Charlotte, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689694671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Marl, DO has received a total of $2,271 in payments from pharmaceutical and medical device companies, with $150.74 received in 2024. These payments were reported across 160 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,262).
As a Medicare-enrolled provider, Marl has provided services to 2,504 Medicare beneficiaries, totaling 3,395 services with total Medicare billing of $246,738. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Charlotte, MI
- Active Since 07/20/2006
- Last Updated 06/14/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689694671
Products in Payments
- Ozempic (Drug) $237.87
- ELIQUIS (Drug) $180.93
- VRAYLAR (Drug) $165.84
- Victoza (Drug) $134.96
- XARELTO (Drug) $110.60
- SYMBICORT (Drug) $87.10
- UBRELVY (Drug) $83.57
- CHANTIX (Drug) $69.37
- Myrbetriq (Drug) $68.35
- JANUVIA (Drug) $63.33
- TRULICITY (Drug) $62.90
- TRELEGY ELLIPTA (Drug) $62.79
- INVOKANA (Drug) $57.55
- TOUJEO (Drug) $56.47
- Prolia (Biological) $52.58
- SYMPROIC (Drug) $50.04
- Saxenda (Drug) $43.46
- Trintellix (Drug) $41.82
- SPIRIVA RESPIMAT (Drug) $38.70
- AIMOVIG (Biological) $35.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Ryan Jacobs, Md, MD
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601